Literature DB >> 15330132

Illicit drug use: can it predict adherence to antiretroviral therapy?

Michela Martini1, Elena Recchia, Paola Nasta, Daniela Castanotto, Francesca Chiaffarino, Fabio Parazzini, Vittorio Agnoletto.   

Abstract

This study analysed the level of adherence to anti-HIV therapies in illegal drug users compared to non-users. Out of 214 patients interviewed. 60 (28%) reported current use of one or more illegal drugs (heroin, cocaine), alcohol (>6 U/day), psychoactive drugs and others. Within the two groups reporting use of heroin and cocaine, the percentage of patients achieving good levels of compliance was higher than among patients who reported not using any substance (50 and 46% vs. 42.3%), among the users of psychoactive pharmaceuticals and alcohol the percentage of high-compliant patients tended to be lower (respectively 26.6 and 30%), but the difference was not significant.

Entities:  

Mesh:

Year:  2004        PMID: 15330132     DOI: 10.1023/b:ejep.0000032353.03967.ef

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  8 in total

1.  Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens.

Authors:  A L Gifford; J E Bormann; M J Shively; B C Wright; D D Richman; S A Bozzette
Journal:  J Acquir Immune Defic Syndr       Date:  2000-04-15       Impact factor: 3.731

2.  Perceptions of disease and therapy are factors influencing adherence to antiretroviral therapy.

Authors:  M Martini; P Nasta; E Ricci; F Parazzini; V Agnoletto
Journal:  Sex Transm Infect       Date:  2000-12       Impact factor: 3.519

Review 3.  Potential factors affecting adherence with HIV therapy.

Authors:  S Mehta; R D Moore; N M Graham
Journal:  AIDS       Date:  1997-11-15       Impact factor: 4.177

4.  Protease inhibitors in the homeless.

Authors:  D Bangsberg; J P Tulsky; F M Hecht; A R Moss
Journal:  JAMA       Date:  1997-07-02       Impact factor: 56.272

5.  Use of zidovudine for drug misusers infected with human immunodeficiency virus.

Authors:  F M Cowan; G Jones; J Bingham; P J Flegg; L R MacCallum; J Whitelaw; D Hargreave; J A Gray; P D Welsby; R P Brettle
Journal:  J Infect       Date:  1989-01       Impact factor: 6.072

6.  Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection.

Authors:  G M Lucas; L W Cheever; R E Chaisson; R D Moore
Journal:  J Acquir Immune Defic Syndr       Date:  2001-07-01       Impact factor: 3.731

7.  Self-reported antiretroviral therapy in injection drug users.

Authors:  D D Celentano; D Vlahov; S Cohn; V M Shadle; O Obasanjo; R D Moore
Journal:  JAMA       Date:  1998-08-12       Impact factor: 56.272

Review 8.  Rethinking nonadherence: historical perspectives on triple-drug therapy for HIV disease.

Authors:  B H Lerner; R M Gulick; N N Dubler
Journal:  Ann Intern Med       Date:  1998-10-01       Impact factor: 25.391

  8 in total
  8 in total

1.  Buffering effects of general and medication-specific social support on the association between substance use and HIV medication adherence.

Authors:  Keren Lehavot; David Huh; Karina L Walters; Kevin M King; Michele P Andrasik; Jane M Simoni
Journal:  AIDS Patient Care STDS       Date:  2011-03       Impact factor: 5.078

Review 2.  Alcohol use and antiretroviral adherence: review and meta-analysis.

Authors:  Christian S Hendershot; Susan A Stoner; David W Pantalone; Jane M Simoni
Journal:  J Acquir Immune Defic Syndr       Date:  2009-10-01       Impact factor: 3.731

3.  A Mediation Model to Explain HIV Antiretroviral Adherence Among Gay and Bisexual Men.

Authors:  Perry N Halkitis; Joseph Palamar
Journal:  J Gay Lesbian Soc Serv       Date:  2008

4.  Reducing sexual risk behaviors and alcohol use among HIV-positive men who have sex with men: a randomized clinical trial.

Authors:  Mary M Velasquez; Kirk von Sternberg; David H Johnson; Charles Green; Joseph P Carbonari; Jeffrey T Parsons
Journal:  J Consult Clin Psychol       Date:  2009-08

5.  Recreational amphetamine use and risk of HIV-related non-Hodgkin lymphoma.

Authors:  Chun Chao; Lisa P Jacobson; Donald Tashkin; Otoniel Martínez-Maza; Michael D Roth; Joseph B Margolick; Joan S Chmiel; Marcy N Holloway; Zuo-Feng Zhang; Roger Detels
Journal:  Cancer Causes Control       Date:  2008-11-15       Impact factor: 2.506

6.  Nonadherence to primary prophylaxis against Pneumocystis jirovecii pneumonia.

Authors:  James D Heffelfinger; Andrew C Voetsch; Glenn V Nakamura; Patrick S Sullivan; A D McNaghten; Laurence Huang
Journal:  PLoS One       Date:  2009-03-25       Impact factor: 3.240

7.  Patient and regimen characteristics associated with self-reported nonadherence to antiretroviral therapy.

Authors:  Patrick S Sullivan; Michael L Campsmith; Glenn V Nakamura; Elin B Begley; Jeffrey Schulden; Allyn K Nakashima
Journal:  PLoS One       Date:  2007-06-20       Impact factor: 3.240

8.  Recreational Drug Use in People Living with HIV in Spain: Factors Associated with Drug Use and the Impact on Clinical Outcomes.

Authors:  Vanessa Castro-Granell; María José Fuster-RuizdeApodaca; Noé Garin; Ángeles Jaén; José Luis Casado; Lorna Leal; Santiago Cenoz
Journal:  AIDS Behav       Date:  2021-05-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.